Diagnosis

Sjogren syndrome

A chronic autoimmune inflammation of the lacrimal and salivary glands with mucosal dryness that manifests as dry eyes and mouth.

Etiology

Cause [vy3]

Classification [vy3]

Pathophysiology [vy3]

  1. Environmental insult in genetically predisposed individual

  2. Epithelial damage --> inflammation --> triggers an aberrant autoimmune response

  3. Aggregations of lymphocytes (CD4 T cells, memory cells and B cells)

  4. Exocrine gland dysfunction --> Reduced tear and saliva production

  5. Clinical presentation:

    • Keratoconjuntivitis sicca: Dry eyes, corneal erosions, vision loss

    • Xerostomia: Dry mouth, dental caries, dental decay, and tooth loss

    • Musculoskeletal: Arthritis (16%), arthralgia (96%), myalgia (70%), myositis (rare)

    • Dermatologic (72%): Xeroderma, eyelid dermatitis, Raynaud phenomenon, cutaneous vasculitis (purpura), cutaneous amyloidosis, and annular erythema

    • Neurologic (5%): Mild cognitive dysfunction, transverse myelitis, neuromyelitis optica, lymphocytic meningitis, cerebral vasculitis, cranial neuropathies (trigeminal, facial, or cochlear nerves), peripheral neuropathies, small fiber neuropathy, sensory ataxic neuronopathy, mononeuritis multiplex and autonomic dysfunction

    • Renal (5%): Tubulointerstitial nephritis, distal renal tubular acidosis, membranoproliferative glomerulonephritis

    • Hematologic: Cytopenias, hypergammaglobulinemia (40%), hypogammaglobulinemia, monoclonal gammopathy, cryoglobulins, leukopenia (20%), anemia (24%), thrombocytopenia (30%)

    • Pulmonary: Cough/dyspnea related to dryness, bronchiectasis, bronchiolitis, interstitial lung disease (nonspecific interstitial pneumonia, lymphocytic interstitial pneumonia, organizing pneumonia), cystic lung disease, pulmonary hypertension

    • Non-Hodgkin lymphoma: An 8.7-fold increased risk

Complications [vy3]

Epidemiology

Incidence per 100.000 [rzd][ocf][ypp][yfg][bea][ers][ugq]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Arthralgia, Arthritis, Ataxia, Cough, Dysgeusia, Dyspepsia, Fasciculations, Fatigue, Keratoconjunctivitis sicca, Lymphadenopathy, Muscle weakness, Myalgia, Paresis, Paresthesia, Raynaud phenomenon, Red eye, Xeroderma, Xerophthalmia, Xerostomia

Clinical findings

Anemia, Anti-SSA, Anti-SSB, Cryoglobulinemia, Hypergammaglobulinemia

Anamneses

None listed.

Localized findings

Pain
Radiates
JointsMuscles
Onset
Gradual (days)
Pattern
Constant
Severity
Mild (1-3)
Rash
Radiates
CaputCollumThoraxAbdomenGenitalArmBackLower body
Distribution
GeneralizedLocalizedMultipleSymmetric
Lesion type
PurpuraUrticaria
Color
Red
Swelling
Radiates
Cavum oris (inside mouth)
Onset
Gradual (days)
Pattern
Constant

Approach

Diagnostic criteria [ers]

  1. Ocular symptoms: dry eyes (>3 months), sensation of sand in eyes, use of tear substitutes >3/day

  2. Oral symptoms: dry mouths (>3 months), swollen salivary glands, frequent drinking to aid swallowing dry food

  3. Ocular signs: Schirmer´s I test (≤5mm in 5 min), Rose Bengal score

  4. Histopathology: focal lymfocytic sialoadenitis

  5. Salivary gland: understimulated flow ≤1.5ml in 15 min, parotid sialography showing sialectasias without obstruction, salivary scintigraphy showing delayed uptake/concentration/excretion

  6. Autoantibodies: Anti-RO(SSA) and/or anti-La(SSB)

Diagnostic criteria [vy3]

Suspicion based on at least 1 of the following:

  1. Labial salivary gland biopsy showing focal lymphocytic sialadenitis (3 points)

  2. Positive anti-Ro/SSA or anti-La/SSB antibodies (3 points)

  3. Ocular staining score ≥5 or van Bijsterveld score ≥4 in at least 1 eye (1 point)

  4. Schirmer’s test result ≤5 mm/5 minutes in at least 1 eye (1 point)

  5. Unstimulated whole salivary flow rate ≤0.1 mL/minute (1 point)

    Score of ≥4 --> Sjögren syndrome

Treatment

There is no known cure for Sjögren syndrome and treatment focuses on relieving symptoms [vy3]

  1. Xerophthalmia: [vy3]

    • Topical tear replacement

    • Topical corticosteroids: risks of glaucoma, cataracts, and infections

    • Topical cyclosporine or tacrolimus

  2. Xerostomia: [vy3][pru]

    • Daily topical fluoride use and antimicrobial mouth rinses

    • Sugar-free chewing gums and sour lemon lozenges for salivary stimulation

    • Muscarinic agonists pilocarpine or cevimeline stimulate salivary flow

  3. Systemic treatment: if moderate to severe extraglandular manifestations [vy3]

    • Glucocorticoids

    • Antimalarial medication (hydroxychloroquine)

    • Steroid-sparing immunosuppressants: methotrexate, azathioprine, mycophenolate mofetil, leflunomide, rituximab or cyclophosphamide

Differential diagnoses

Allergy, Benign tumors of salivary glands, Blepharitis, Celiac disease, Chronic sinusitis, Conjunctivitis, Diabetes mellitus, Drug side effects, Hashimotos thyroiditis, HIV, Hypovolemia, Lymphoma, Malignant tumors of salivary glands, Mumps, Parkinson's disease, Polyneuropathy, Rheumatoid arthritis, Rosacea, Sarcoidosis, Scleroderma, Sialadenitis, Systemic lupus erythematosus


References

[1] Carsons SE, Blum MA. Sjogren Syndrome. [Updated 2025 Jul 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431049/

[2] Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R. Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015 Nov;74(11):1983-9.

[3] Plesivcnik Novljan M, Rozman B, Hocevar A, Grmek M, Kveder T, Tomsic M. Incidence of primary Sjogren's syndrome in Slovenia. Ann Rheum Dis. 2004 Jul;63(7):874-6.

[4] Weng MY, Huang YT, Liu MF, Lu TH. Incidence and mortality of treated primary Sjogren's syndrome in Taiwan: a population-based study. J Rheumatol. 2011 Apr;38(4):706-8.

[5] See LC, Kuo CF, Chou IJ, Chiou MJ, Yu KH. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum. 2013 Dec;43(3):381-6.

[6] Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (Hoboken). 2013 Feb;65(2):244-50.

[7] Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford). 2006 Feb;45(2):187-91.

[8] Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O'Fallon WM, Fox PC. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001 Jun;76(6):593-9.

[9] Kruszka P, O'Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician. 2009 Mar 15;79(6):465-70.

[10] http://emedicine.medscape.com/article/332125 (2014-01-02); [Medscape]

Scroll to top